InvestorsHub Logo
icon url

Sam81

01/13/16 10:58 AM

#69026 RE: Mogwai #69024

Mog,

"It could be a total failure, in which case the company will go BK"

You are seriously out of your mind...bankrupt ?!?!?

Let me refresh your memory that Amarin is not a company with a do or die drug trial/approval
The company already has an approved indication for the drug which is selling in the market and gaining market share and generating revenues. If Red-it is a failure, the drug is still there, selling and competing with generics with huge patent portfolio....etc At that point, the management might decide to sell to BP at a very low valuation. Based on current sales and expectations and taking into account the debt obligations, that will be in low single digits
So just to make things clear and for you to stop your scare tactics, even with a failure, the company will not go bankrupt, as simple as that
So please spare us your philosophical views which are clearly being said for a purpose, whether personal, whether for your big boss or whether from a hatred towards people who never been nice to you in the past....i do not know and don't care to know, so please take a chill pill and stop the scare non-sense tactics
icon url

acuzuss

01/13/16 11:14 AM

#69029 RE: Mogwai #69024

you're a smart guy. i think you can figure out why there aren't buyout offers. here's a couple glaring reasons:
1. NCE is not officially in OB and Watson isn't out of the picture.
2. 1st A case isn't settled.

why make an offer with Reduce-IT interim around the corner? If it's not stopped then make your offer with CVR's but only after NCE is in OB and we know where the 1st A case lands.
icon url

AmrnBull

01/13/16 12:12 PM

#69037 RE: Mogwai #69024

Can you please state your position in AMRN! Are you a long or a short or someone that volunteers his time to create doubt in this company.

I am long so what are you...